$893.47
-0.52[-0.06%]
Last update: 3:33PM Get Real Time Here
Regeneron Pharmaceuticals
(NASDAQ:REGN)Overview Rating
Good
Regeneron Pharmaceuticals Stock (NASDAQ:REGN), Quotes and News Summary
Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.
| Open | $913.970 |
| Close | - |
| Volume / Avg. | 263.769K / 474.169K |
| Day Range | 891.460 - 920.730 |
| 52 Wk Range | 684.805 - 998.325 |
| Market Cap | $98.069B |
| P/E Ratio | 25.697 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 28 |
| Short Interest | 1.54% |
| Days to Cover | 3.73 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Regeneron Pharmaceuticals, Inc.
Sector
Health Care
Industry
Biotechnology
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, c...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Regeneron Pharmaceuticals (REGN) stock?
You can purchase shares of Regeneron Pharmaceuticals (NASDAQ: REGN) through any online brokerage.
Who are Regeneron Pharmaceuticals's (REGN) competitors?
Other companies in Regeneron Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Regeneron Pharmaceuticals (REGN) stock?
The latest price target for Regeneron Pharmaceuticals (NASDAQ: REGN) was reported by UBS on Wednesday, April 17, 2024. The analyst firm set a price target for 1099.00 expecting REGN to rise to within 12 months (a possible 23.00% upside). 67 analyst firms have reported ratings in the last year.
Current Stock Price for Regeneron Pharmaceuticals (REGN)?
The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $893.47 last updated Today at April 19, 2024 at 3:33 PM EDT.
Does Regeneron Pharmaceuticals (REGN) pay a dividend?
There are no upcoming dividends for Regeneron Pharmaceuticals.
When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?
Regeneron Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Regeneron Pharmaceuticals (REGN) going to split?
There is no upcoming split for Regeneron Pharmaceuticals.
What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?
Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.